Pleio, Inc. Expands with the American Pharmacy Alliance

Pleio GoodStart® now being offered to 12,000+ APA Pharmacy Customers

Boston, MA (PRWEB) March 23, 2016

Pleio, Inc., announces that its GoodStart® patient adherence support program is now being offered to customers of the American Pharmacy Alliance (APA) as part of the APA Advantage Program. The APA is a technology partnership of leading pharmacy software companies that supply prescription processing systems to more than 12,000 independent and small chain pharmacies throughout the United States. APA customers will also have the option of participating in GoodStart® through the APA's preferred business agreement with Pharmacy Data Network (PDN).

"Our goal at the APA is to provide access to beneficial products and services for independent and small chain pharmacies, their customers, and software vendors nationwide." said John Hobson, APA's Director of Business Development. "We want to ensure access to those programs that provide significant benefits, and the Pleio GoodStart® program has been proven to improve quality and increase revenue."

Mark Connors, CEO of Pleio, said, "We're extremely excited about the expansion of our relationship with the APA and our partnership with PDN. With over 12,000 independent pharmacies served by its industry leading software vendors, this support represents a huge opportunity to broaden our network in order to improve Star ratings and quality scores for community pharmacy."

For more information about the American Pharmacy Alliance, or to learn more about our APA members, please visit www.ameripharm.com, or contact John Hobson at jhobson@ameripharm.com.

To learn more about Pharmacy Data Network, please visit www.pharmacydatanetwork.com, or contact Chuck Welch at chuck.welch@pharmacydatanetwork.com.

About Pleio, Inc.

Pleio is a leader in patient engagement and medication adherence. We instill lasting behavior change in patients though multi‐channel engagement involving artfully scripted, non‐clinical conversations with GoodStart Mentors™, digital outreach, and seamless integration with community pharmacy. Pleio's proprietary adherence lifecycle management platform controls the timing and nature of all patient touch points in the GoodStart™ program, which delivers revenue, improves quality, and reduces medical costs.

Pleio selected by Denver Health Medical Plan to facilitate goal of continued Star Ratings growth

Pleio's proven peer-to-peer approach to adherence integrates seamlessly with health plan's own clinical resources to offer a unified support experience for members

Boston, MA (PRWEB) January 25, 2016

Denver Health Medical Plan, Inc. ("DHMP"), the 2015 Pharmacy Quality Alliance Quality Improvement Award winner, has selected Pleio, Inc. to assist in their objective of continued growth of DHMP Star ratings by increasing the adherence of their Medicare members.

Michelle Beozzo, Pharm.D., Director of Pharmacy for DHMP stated "We are excited to partner with Pleio; their non-clinical peer-to-peer behavioral change approach to improving member adherence, while integrating with our clinical pharmacists, is not only innovative, but a winning combination."

The Pleio GoodStart® medication adherence solution integrates live outreach to members utilizing GoodStart Mentors™, data analytics, and a menu of digital adherence tactics to help members succeed on therapy and deliver dramatic improvements in adherence. Pleio has demonstrated increases of between 3% and 7% in Proportion of Days Covered (PDC) in broad, non-risk stratified populations of Star rated members.

Mark Connors, CEO commented that "since 2006, the Pleio GoodStart program has improved the health of millions of members through better adherence to medications. We are pleased to have the opportunity to work with such a progressive health plan, and amplify the effectiveness of their clinical pharmacists."

About Denver Health Medical Plan, Inc. (DHMP)

Denver Health Medical Plan, Inc. is a nonprofit health plan created in 1997 to provide quality, accessible and affordable health care services in the Denver area. In partnership with the DHMP provider network, Denver Health Medical Plan, Inc. continually seeks to improve the health and wellbeing of its members by promoting wellness and disease prevention, providing access to culturally diverse comprehensive health services and enabling members to play an active role in their health care. Denver Health Medical Plan, Inc. provides health insurance for 20,000 members in the Denver area as well as administers benefits for a 65,000 member Medicaid Managed Care Organization (MCO). www.DenverHealthMedicalPlan.org

About Pleio, Inc.

Pleio is a leader in patient engagement and medication adherence. We instill lasting behavior change in patients though multi-channel engagement involving artfully scripted, non-clinical conversations with GoodStart Mentors™, digital outreach, and seamless integration with retail pharmacy. Pleio's proprietary adherence lifecycle management platform controls the timing and nature of all patient touch points in the GoodStart™ program, which delivers revenue, improves quality, and reduces medical costs.

Pleio and Pharmacy Data Network partner to extend reach of premium adherence services within community pharmacy

Partnership deepens Pleio's network of national pharmacies and allows Pharmacy Data Network to offer Pleio GoodStart® to its customers

Boston, MA (PRWEB) December 4, 2015

Through this partnership, Pleio will deliver its industry-leading Pleio GoodStart® medication adherence solution to millions of additional patients using pharmacy data from Pharmacy Data Network's (PDN) pharmacy software system vendors. Pleio GoodStart® integrates live outreach by GoodStart Mentors™, data analytics, and a menu of digital adherence tactics to help patients succeed on therapy and improve adherence measures such as Proportion of Days Covered (PDC).

Pleio's CEO Mark Connors says, "Our partnership with PDN will allow Pleio to improve Star ratings for our community pharmacy and health plan partners, improve the health and wellness of their loyal patients, and lower overall healthcare costs."

PDN seeks to ease the burden on system vendors who receive numerous demands for data, while meeting the business needs of the many community pharmacies it serves. PDN's CEO Chuck Welch says, "Our partnership with Pleio is yet another example of our commitment to helping community pharmacies bring affordable, practical programs to their customers in their surrounding neighborhoods."

About Pharmacy Data Network, LLC.

Founded in 2015, PDN is a healthcare data aggregator that integrates diverse data libraries into one common database for use in the healthcare sector. Collaborating with numerous pharmacy operating systems, PDN has created one standard interface where healthcare data can be entered, collected, stored, and shared across all systems involved in the network. www.pharmacydatanetwork.com

About Pleio, Inc.

Pleio is a leader in patient engagement and medication adherence. We instill lasting behavior change in patients though multi-channel engagement involving artfully scripted, non-clinical conversations with GoodStart Mentors™, digital outreach, and seamless integration with retail pharmacy. Pleio's proprietary adherence lifecycle management platform controls the timing and nature of all patient touch points in the GoodStart™ program, which delivers revenue, improves quality, and reduces medical costs.

Pleio, Inc. Expands Adherence Offerings For Retail Pharmacy

Pleio, Inc. adds pharmacy-focused GoodStart® patient support programs designed to boost PDC scores and customer loyalty

Boston, MA (PRWEB) August 21, 2014

Pleio, Inc., a leader in patient engagement and medication adherence, is launching a new suite of services for retail and outpatient pharmacy. These patient-centric offerings assist retail pharmacy by applying proven behavior shaping programs to specific disease states and drug classes, resulting in increased medication adherence, higher PDC scores and improved health plan STAR ratings. As such, Pleio's PDC-targeted offerings align retail's desire to meet health plan requirements with its commitment to patient adherence and well-being.

"We are excited to be able to offer a new menu of patient support programs specifically designed to address some of retail pharmacy's most pressing business needs," says Pleio Chief Executive Officer, Mark Connors.

The new pharmacy-focused services can be seamlessly integrated into any pharmacy's existing clinical or loyalty programs via multiple channels including pharmacy Web site, smart phone apps, email and text. The deep customer relationships that Pleio is able to develop on behalf of pharmacy open a unique channel of communication with patients, allowing the collection of valuable customer insights. Pleio's pharmacy-focused programs are supported by extensive reporting and data analysis, including PDC performance data, industry benchmarking, and store level revenue impact.

Further reinforcing its commitment to pharmacy, Pleio has hired industry insider, Beth Bell, as Senior Vice President of Pharmacy Services. Ms. Bell will lead Pleio's efforts to deliver innovative pharmacy-centric services that help our trading partners meet their critical financial and results-driven objectives. "I am thrilled to have joined the Pleio team and look forward to building on the successes of the core GoodStart programs with a suite of business services that allow us to reach patients wherever they are in their journey to wellness," says Ms. Bell. "While many in the industry tout the benefits of predictive analytics, Pleio not only identifies those customers who need behavioral change, but actually effect that change."

About Pleio, Inc.

Pleio is a leader in patient engagement and medication adherence. Combining live human encounters with technology, Pleio successfully brings people together to develop and deliver the world's most effective solutions to the biggest challenge of medicine: medication adherence. Pleio GoodStart® is a registered trademark of Pleio, Inc.

Pleio GoodStart® Drives 41% Improvement in Medication Adherence PDC Rate

Pleio Inc. released new data from its GoodStart adherence program demonstrating that 41% more patients achieved a PDC (Proportion of Days Covered) medication adherence rate of at least 80% which is the threshold for patients to be considered highly adherent to their medications.

Tampa Bay, FL (PRWEB) April 03, 2014

Pleio Inc. released new data from its GoodStart adherence program for hypertensive patients. The analysis was conducted on patients with hypertension who participated in their pharmacy's GoodStart adherence program between 2010 and 2013 and received at least two live follow-up calls and customized GoodStart Minute™ health messages for up to 21 days. Compared to a similar control group, 41% more patients achieved a PDC (Proportion of Days Covered) medication adherence rate of at least 80% which is the threshold for patients to be considered highly adherent to their medications.

"The data demonstrated that targeting appropriate patients and engaging them in a series of live phone discussions, accompanied by strategically timed virtual touches like customized SMS or IVR messages, holds the potential for helping health plans meet and even surpass CMS PDC goals," says Pleio Chief Medical Officer, Dr. Bram Greenberg.

The intervention group consisted of patients who received at least two live calls from the GoodStart program. The control group consisted of patients who had no contact with the GoodStart program and who contemporaneously picked up a prescription in a participating chain. The groups were matched in age, gender and geography.

About Pleio, Inc.

Pleio brings people together to develop and promote the world's best solutions to the biggest challenge of medicine: medication adherence. Pleio GoodStart® is a registered trademark of Pleio Inc.

Pleio GoodStart® Meets HIPAA Omnibus Rule Standards

Pleio Inc. is proud to announce that it has developed a fully HIPAA-compliant telephonic process for obtaining individual authorizations (“IAs”) in connection with its GoodStart medication adherence programs.

Boston, MA (PRWEB) August 26, 2013

Pleio Inc. is proud to announce that it has developed a fully HIPAA-compliant telephonic process for obtaining individual authorizations (“IAs”) in connection with its GoodStart medication adherence programs. The new process delivers in plain language all of the required elements of a HIPAA IA and then captures and digitizes a telephonic verbal consent.

Pleio is encouraged by the Omnibus Rule issued by the Department of Health and Human Services (“DHHS”) which takes effect on September 23, 2013. In its preliminary commentary to the Rule, DHHS acknowledges the value of Pharmacy-driven medication adherence programs as part of health care treatment and operations under HIPAA. Under the new rule, however, patients must be properly informed when those programs are subsidized and must authorize communications made in connection with the subsidized programs. Pleio has developed and successfully tested a telephonic IA process which meets the legal requirements of HIPAA.

“Several studies have suggested that low health literacy is directly associated with poor medication adherence,” says Pleio Inc. CEO, Jean Lalonde. “Through verbal explanations and digital authorizations enabled by HIPAA and the federal E-Sign Act, patients with low literacy can gain access to trusted support where and when they need it, in language they can understand.”

Since 2009, Pleio has helped more than 15,000 pharmacies implement phone-based support programs for their patients, in turn helping millions of Americans who prefer spoken more than written words. Pleio’s initiative relative to the new Omnibus Rule will ensure that patients with low health literacy, patients who live in isolation, and overburdened caregivers will continue to benefit from Pleio’s phone-based GoodStart® programs delivered by Pharmacies across the country.

Pleio GoodStart® is a registered trademark of Pleio Inc.

Pleio Says Omnibus Rule is Positive for Medication Adherence, Positive for Health Literacy, Positive for Pharmacy, as Program Sponsorships Double in 2013

Pleio Inc. is encouraged by the Omnibus Rule issued by the Department of Health and Human Services. The Rule confirms the vital role of pharmacy-driven medication adherence programs as part of health care treatment and operations under HIPAA.

Las Vegas, NV (PRWEB) August 12, 2013

Pleio Inc. is encouraged by the Omnibus Rule issued by the Department of Health and Human Services. The Rule confirms the vital role of pharmacy-driven medication adherence programs as part of health care treatment and operations under HIPAA. Patients with low health literacy, patients who live in isolation, and overburdened caregivers will continue to benefit from Pleio’s phone-based GoodStart® programs delivered by pharmacies across the country. Patients must be properly informed and provide their verbal or written authorization – a practice that Pleio has implemented with its 40 pharmacy chain partners since 2009.

Low health literacy is directly associated with poor medication adherence. Through verbal explanations and digital authorizations enabled by HIPAA and the federal E-Sign Act, patients with low literacy can gain access to trusted support where and when they need it, in language they can understand. Since 2009, Pleio has helped more than 15,000 pharmacies implement phone-based support programs for their patients, in turn helping millions of Americans who prefer spoken more than written words. The Omnibus Rule’s new requirements take effect on September 23, 2013.

Pleio GoodStart® is a registered trademark of Pleio Inc.

Pleio GoodStart Patient Support Program Boosts Adherence and Pharmacy Loyalty

Patients Fill 2 Additional Prescriptions, More Likely to Recommend Pharmacy New data shows that pharmacies can improve medication adherence and boost customer loyalty by expanding the scope of patient support to include phone follow-up and customized daily health tips.

Denver, Colorado (PRWEB) August 27, 2012

Pleio released data today which demonstrates that the Pleio GoodStart® patient support program boosts medication adherence and pharmacy loyalty.

Prescription data reveals that Pleio’s 100-day protocol of live phone discussions with pharmacy personnel, and customized daily health tips by text message, IVR and e-mail, improves Rx consumption. Patients 40 to 60 years of age refilled an average of 52 more pills during their first 450 days on a once-a-day pill. In a recent survey, 95% of GoodStart participants of all ages said the program made them more likely to recommend their pharmacy to a friend. The data was released at the National Association of Chain Drug Stores conference in Denver.
Prescription data was collected daily for 18 months from over 20 pharmacy chains who use Pleio GoodStart, and analyzed using Pleio Tandem™ Analytics. The prescription data from 23,783 patients included a similar patient control group who were not reached to participate in the Pleio GoodStart program. The results are considered very highly significant (P<.001).

In a live phone survey of 320 patients who recently participated in the GoodStart program, it was learned that 45% of patients had already told a friend, family member or healthcare provider about the program, 79% of patients felt the GoodStart program helped them feel better about their medication, and 95% said they would be more likely to recommend their pharmacy to a friend as a result of the GoodStart Program.

According to CEO Jean Lalonde, “Pharmacy is in the right place at the right time when it comes to medication adherence. Pleio helps pharmacies expand their role by highly customized phone conversations and health tips delivered however patients like, whenever they like. Pleio helps expand pharmacy by improving the support that innovative pharmacies can offer their patients.”

Pleio GoodStart® is a registered trademark of Pleio Inc. Pleio Tandem™ is a trademark of Pleio Inc.

Pleio GoodStart® Helping Pharmacies Bring Busy Boomers Back

Pleio GoodStart® medication adherence program serves young baby boomers aged 48 to 57 more than any other age group. Baby boomers who participated in their pharmacy’s GoodStart medication follow-up service for a blood pressure medication purchased 84 more pills over 18 months than patients in a control group.

Boston, MA (PRWEB) November 29, 2011

Pleio Inc. reports that to date in 2011, its Pleio GoodStart® medication adherence program serves young baby boomers aged 48 to 57 more than any other age group. According to prescription data collected from 2008 to 2010 through Pleio Tandem™, baby boomers who participated in their pharmacy’s GoodStart medication follow-up service for a blood pressure medication purchased 84 more pills over 18 months than patients in a control group.

How Pleio GoodStart® Appeals to Busy Boomers

Pleio GoodStart® is customized, convenient and continuous. It helps pharmacies provide busy customers with the support they need when they need it most, during their first 100 days with a new prescription. Pleio continuously analyzes patient insight data and Rx data to produce a unique experience for every participant during their first 100 days of therapy. Through live discussions with trained Pleio GoodStarters™, Just-in-Time Pharmacist support, and daily GoodStart Minutes™, Pleio GoodStart® helps patients take their meds as directed and refill their prescriptions when expected.

Pleio GoodStart® Recognized as a Best Practice in Medication Adherence

Experience gained through alliances with several pharmaceutical companies and pharmacy chains have contributed to Pleio’s success. The 2010 White Paper on The Future of Pharmacy by the Center for Health Transformation named Pleio GoodStart® one of the country’s top adherence ‘Best Practices’. The 2011 URAC ‘Call to Action on Adherence’ identified Pleio as the premier example of multi-faceted adherence programs. Pleio GoodStart® programs are now offered to patients through more than 24 pharmacy chains across the country.

Pleio GoodStart® is a registered trademark of Pleio Inc. Pleio Tandem™ is a trademark of Pleio Inc.

Pleio Helps Kerr Drug Deliver Customized Medication Follow-Up: Use of Blood Pressure Medication Improves

Analysis of prescription data confirms that the Pleio GoodStart adherence program helped Kerr Drug pharmacy customers take blood pressure medication as directed. As a result of Pleio program, men refilled an average of 4 additional prescriptions, and women refilled an average of 2 more prescriptions, over an 18-month period.

Raleigh, North Carolina (PRWEB) October 14, 2010

Prescription data collected by Kerr Drugs over two years reveals that patients who participated in a free medication follow-up service offered by their Kerr pharmacy took an average of 84 additional doses of their blood pressure medication over their first 18 months of therapy compared to a similar control group.

Pleio GoodStart™ helped Kerr customers aged 40-70 improve adherence to a once-daily blood pressure medication regimen through its integrated offering of phone-based coaching, daily voice and text message reminders, and medication therapy management services carried out by Kerr pharmacists. Patients were enrolled into the program by Kerr pharmacists shortly after picking up their prescriptions, and most patients stayed with the program until the end of the service, 100 days later.

Thirty months of prescription data for 547 patients was collected from Kerr pharmacies for the period of January 2008 to June 2010. Patients of comparable age and sex were selected for the 670-person control group.

The Pleio GoodStart™ program was the first of its kind ever implemented at Kerr. According to Mark Gregory, COO of Kerr Drugs, “Pleio was able to make our pharmacists equal partners in this project, while rolling out new technology and medication adherence expertise that helped amplify Kerr’s interest in adherence and our belief in our pharmacists.”

According to Mark Connors, Co-CEO of Pleio, “the Kerr GoodStart project was one of our first multi-channel programs, and we were very lucky to work with a chain like Kerr with a reputation in adherence of a leading innovator. It’s great to offer a service that helps so many people simply take their heart medication the way that their doctors prescribed.”

Pleio GoodStart™ is a registered trademark of Pleio Inc.

Pleio Helps Chains Boost Adherence in Boomers: 84 More Pills per Patient Over 18 Months

Prescription data collected by three pharmacy chains over two years reveals that ‘baby boomers’ who participated in a Pleio GoodStart™ Program offered by their pharmacy took an average of 84 additional doses of their blood pressure medication over their first 18 months of therapy compared to a similar control group.

Montreal, QC and Boston, MA (PRWEB) August 19, 2010

Prescription data collected by three pharmacy chains over two years reveals that ‘baby boomers’ who participated in a Pleio GoodStart™ Program offered by their pharmacy took an average of 84 additional doses of their blood pressure medication over their first 18 months of therapy compared to a similar control group.

Pleio GoodStart™ helped chains improve adherence to a once-daily blood pressure medication regimen through its integrated offering of phone-based coaching, daily voice and text message reminders, and medication therapy management services carried out by chain pharmacists. Patient enrolment occurred from May 2008 to March 2009.

Thirty months of prescription data for 404 patients was collected from pharmacies in North Carolina, Virginia, and Maryland for the period of January 2008 to June 2010. Patients of comparable age and sex were selected for the 670-person control group.

Pleio GoodStart™ is a registered trademark of Pleio Inc.

Patients who Participated in Pleio GoodStart™ Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient

Patients who participated in Pleio GoodStart™ refilled 30% sooner and 40% more, averaging 2 additional Rx refills per patient during first 9 months of therapy.

Philadelphia, PA (PRWEB) October 26, 2009

Health Support Systems, Inc. (Pleio) announces updated results of the Pleio GoodStart™ medication adherence program. Retrospective analysis of retail pharmacy prescription data from 1,776 patients taking a chronic cardiovascular medication between May 2008 and September 2009, revealed that Pleio GoodStart™ had a highly significant impact on medication adherence, resulting in patients refilling an average of two additional 30-day prescriptions during their initial 9-month period on the medication (p<0.001).


Source: Pleio retail pharmacy prescription data from US Mid-Atlantic Pharmacy Chain, May 2008 -- October 2009

Data also showed that patients who participated in the GoodStart™ program refilled their prescriptions an average of ten days sooner than control group participants. Collectively, these data demonstrate a significant, sustained improvement in patient medication adherence with the Pleio GoodStart™ program.

Pleio GoodStart™ is a registered trademark of Pleio Inc.